13F Pro

SEC Form 4 reporting owner

Goncalves Joana

Goncalves Joana has filed 47 Form 4 transactions reported between December 19, 2025 and September 15, 2026, as Chief Medical Officer of Oruka Therapeutics, Inc..

Name as filed: Goncalves Joana

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$4.5M
35 lines
Companies
1
with Form 4 filings
Latest transaction
Sep 15, 2026
transaction date

Roles and reported holdings

  • ORKAOruka Therapeutics, Inc.
    Dec 19, 2025 – Sep 15, 2026

    Chief Medical Officer

    Held directly31,771 sh as of Sep 15, 2026 · Form 4

    24 months: $4.5M sold

Transaction history

All 47 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct947$91K@ $95.71Form 4
Sep 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct100$9K@ $94.22Form 4
Sep 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct1,366$127K@ $92.99Form 4
Sep 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct3,150$290K@ $92.03Form 4
Sep 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct2,384$217K@ $91.10Form 4
Sep 15, 2026ORKAChief Medical OfficerOption exerciseCode M · direct3,500$24K@ $6.84Form 4
Aug 17, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct2,480$279K@ $112.56Form 4
Aug 17, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct3,320$372K@ $112.01Form 4
Aug 17, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct300$33K@ $110.52Form 4
Aug 17, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct900$99K@ $109.65Form 4
Aug 17, 2026ORKAChief Medical OfficerOption exerciseCode M · direct3,500$24K@ $6.84Form 4
Jul 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct300$26K@ $87.25Form 4
Jul 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct3,803$330K@ $86.68Form 4
Jul 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct2,497$214K@ $85.86Form 4
Jul 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct400$34K@ $84.36Form 4
Jul 15, 2026ORKAChief Medical OfficerOption exerciseCode M · direct3,500$24K@ $6.84Form 4
Jun 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct947$66K@ $69.69Form 4
Jun 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct300$21K@ $70.62Form 4
Jun 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct5,064$352K@ $69.42Form 4
Jun 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct1,636$112K@ $68.38Form 4
Jun 15, 2026ORKAChief Medical OfficerOption exerciseCode M · direct3,500$24K@ $6.84Form 4
May 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct100$6K@ $63.52Form 4
May 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct2,100$131K@ $62.42Form 4
May 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct4,800$295K@ $61.56Form 4
May 15, 2026ORKAChief Medical OfficerOption exerciseCode M · direct3,500$24K@ $6.84Form 4
Apr 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct500$34K@ $67.38Form 4
Apr 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct2,273$151K@ $66.56Form 4
Apr 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct4,227$278K@ $65.73Form 4
Apr 15, 2026ORKAChief Medical OfficerOption exerciseCode M · direct3,500$24K@ $6.84Form 4
Mar 16, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct641$26K@ $41.30Form 4
Mar 16, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct1,177$49K@ $41.94Form 4
Mar 16, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct2,902$120K@ $41.20Form 4
Mar 16, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct2,921$117K@ $40.11Form 4
Mar 16, 2026ORKAChief Medical OfficerOption exerciseCode M · direct3,500$24K@ $6.84Form 4
Feb 17, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct936$31K@ $32.78Form 4
Feb 17, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct6,064$196K@ $32.30Form 4
Feb 17, 2026ORKAChief Medical OfficerOption exerciseCode M · direct3,500$24K@ $6.84Form 4
Jan 23, 2026ORKAChief Medical OfficerGrant or awardCode A · direct130,000—Form 4
Jan 23, 2026ORKAChief Medical OfficerGrant or awardCode A · direct32,500—Form 4
Jan 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct2,619$84K@ $32.24Form 4
Jan 15, 2026ORKAChief Medical OfficerOpen-market saleCode S · direct4,381$138K@ $31.56Form 4
Jan 15, 2026ORKAChief Medical OfficerOption exerciseCode M · direct3,500$24K@ $6.84Form 4
Dec 19, 2025ORKAChief Medical OfficerOpen-market saleCode S · direct3,080$97K@ $31.58Form 4
Dec 19, 2025ORKAChief Medical OfficerOpen-market saleCode S · direct1,492$46K@ $30.70Form 4
Dec 19, 2025ORKAChief Medical OfficerOpen-market saleCode S · direct1,787$53K@ $29.62Form 4
Dec 19, 2025ORKAChief Medical OfficerOpen-market saleCode S · direct641$18K@ $28.53Form 4
Dec 19, 2025ORKAChief Medical OfficerOption exerciseCode M · direct3,500$24K@ $6.84Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.